Immuneering to Participate in September Investor Conferences

NEXT STORY
MacroGenics to Participate in Upcoming Investor Conferences
PREV STORY
Fate Therapeutics to Present at Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellworks AI-Driven Biosimulation Predicted Chemo-resistance in AML and MDS Patients with 90% Accuracy

Prospective Study Successfully Identified Mechanisms for AML & MDS Patients’ Nonresponse to Standard Care ...

author_avatar
NASDAQ Market News

Merit Medical Signs Agreement to Acquire Cianna Medical, Inc.

SOUTH JORDAN, Utah, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: ...

author_avatar
NASDAQ Market News

UroGen Pharma Announces Pricing of Initial Public Offering

RA’ANANA, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd., a clinical stage ...

author_avatar
NASDAQ Market News